YS Biopharma Co. Ltd. (YS)
NASDAQ: YS
· Real-Time Price · USD
1.02
0.09 (9.68%)
At close: May 24, 2024, 10:00 PM
YS Biopharma Revenue
YS Biopharma reported an annual revenue of $614.96M, reflecting a 7.24% growth. For the quarter ending March 31, 2024, YS Biopharma generated $135.53M in revenue.
Revenue (ttm)
614.96M
Revenue Growth
7.24%
Price / Sales Ratio
0
Revenue / Employee
795.55K
Employees
773
Market Cap
192.09M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Mar 31, 2025 | 614.96M | +7.24% |
| Mar 31, 2024 | 573.42M | -16.56% |
| Mar 31, 2023 | 687.2M | +36.63% |
| Mar 31, 2022 | 502.95M | +95.69% |
| Mar 31, 2021 | 257.02M | n/a |